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First Africa non-communicable 
disease research conference 
2017: sharing evidence and 
identifying research priorities
Non-communicable diseases (NCDs) prevalence is rising fastest in lower income settings, and with 
more devastating outcomes compared to High Income Countries (HICs). While evidence is consist-
ent on the growing health and economic consequences of NCDs in sub-Saharan Africa (SSA), spe-
cific efforts aimed at addressing NCD prevention and control remain less than optimum and country 
level progress of implementing evidence backed cost-effective NCD prevention approaches such as 
tobacco taxation and restrictions on marketing of unhealthy food and drinks is slow. Similarly, in-
creasing interest to employ multi-sectoral approaches (MSA) in NCD prevention and policy is im-
peded by scarce knowledge on the mechanisms of MSA application in NCD prevention, their coor-
dination, and potential successes in SSA. In recognition of the above gaps in NCD programming and 
interventions in Africa, the East Africa NCD alliance (EANCDA) in partnership with the African Pop-
ulation and Health Research Center (APHRC) organized a three-day NCDs conference in Nairobi. 
The conference entitled “First Africa Non-Communicable Disease Research Conference 2017: Shar-
ing Evidence and Identifying Research Priorities” drew more than one hundred fifty participants and 
researchers from several institutions in Kenya, South Africa, Nigeria, Cameroon, Uganda, Tanzania, 
Rwanda, Burundi, Malawi, Belgium, USA and Canada. The sections that follow provide detailed over-
view of the conference, its objectives, a summary of the proceedings and recommendations on the 
African NCD research agenda to address NCD prevention efforts in Africa.
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Non-communicable diseases (NCDs) such as cardiovascular disease (CVDs), cancers, chronic respiratory 
diseases, diabetes and mental illnesses, are a significant and increasing cause of illnesses, disability and 
deaths globally [1]. For instance, of the 54 · 7 million global deaths in 2016 [2], 39.5 million, or 72 · 3%, 
were due to NCDs, with majority occurring within low and lower-middle income countries (LLMICs) 
[1]. Notably, NCDs rise is also faster in lower income countries and populations (the people forming the 
bottom billion), with an earlier age of onset and higher premature mortalities compared to high-income 
countries (HICs) [3]. While there has been profound progress made in health of populations over the last 
three decades, including in the sub-Saharan Africa (SSA) – such as improved life expectancy – the rise of 
NCDs threatens to reverse these gains and stall social and economic developments [4]. Arguably – NCDs 
are as much an economic problem, as they are a health epidemic [5]. Cumulative economic losses from 
NCDs and mental disorders could surpass US$47 trillion (which is more than 75% of global GDP) by 
2030 [6]. Recent studies have increasingly shown the intimate link between NCDs and poverty, in which 
NCDs drain household resources [7], diminish labor supply and productivity [8], as well as impose cat-
astrophic expenditures on poor and uninsured households during treatment of chronic NCD conditions 
[9]. What is also known is that majority of low income NCD patients tend to use out of pocket payment 
when seeking medical care [10]. Out-of-pocket payments for health care services drive about 100 million 
people into poverty every year [11]. Therefore, emerging market economies (such as those in SSA) will 
be hit harder, even as they continue to grow, if the rising NCD burden remains unchecked [6].
Despite the growing evidence of the health and economic consequences of NCDs in SSA, efforts aimed 
at prevention and control have been less than optimum [12-14]. Challenges such as acute funding, health 
system challenges, competing interests from industry actors (such as salt, tobacco and alcohol industries) 
as well as low NCD awareness levels, remain significant impediments in efforts against NCDs in SSA [15]. 
Consistent with this evidence, the 2017 WHO NCD Progress Monitor report revealed that less than half 
of WHO Member States have set NCD targets/indicators to track progress of implementing NCD “best 
buys” [16]. Also, there are worryingly slow rates of progress at country level in implementing the NCD 
prevention approaches such as tobacco taxes, strengthening health systems, and restrictions on market-
ing of unhealthy food and drink products to children [17]. Studies suggest that modest investments to 
implement cost-effective CVDs interventions in SSA could yield profound reductions in mortalities (from 
coronary artery disease and stroke) and also reduce economic losses, nevertheless, such opportunities 
have not been leveraged by SSA governments [18]. Most importantly, since the drivers of NCD epidemic 
include epidemiological, demographic and economic transitions [19], efforts to deal with NCDs require 
multisectorial engagement, involving both health and non-health sectors aligning their goals and activi-
ties across multiple levels [20].
There are increasing calls to adopt a multi-sectoral approach (MSA) in developing policies and programs 
to address NCD burden [21]. MSA basically refers to activities undertaken by various non-health sectors 
to modify health or health-related outcomes or the determinants of health or health equity [22]. Howev-
er, the mechanisms of MSA application, coordination, and successes in NCD prevention remain poorly 
characterized in SSA countries [23]. Furthermore, the absence of an active African civil society NCD fo-
rum curtails the coordination of NCD prevention research efforts in Africa. While there have been previ-
ous attempts to establish an African NCD civil society organizations (CSOs) network, these efforts have 
been characterized by challenges such as retaining interest of network partners, meeting stakeholder and 
partner expectations and scarcity of dedicated resources [24,25]. Nevertheless, an African CSOs NCD fo-
rum could be a platform to share progress in research, disseminate lessons learnt and replicate them in 
various other settings, formulation of research priorities and networks of partnerships and collaboration 
relevant to Africa.
In recognition of the above gaps in NCD programming and interventions within Africa, a three-day NCDs 
research conference was organized by the East Africa NCD alliance in partnership with the African Pop-
ulation and Health Research Center (APHRC) in Nairobi, Kenya, in January 25-27, 2017.
The conference objectives included:
a)  to disseminate evidence on the analysis of NCDs prevention policy development and the role of 
multi-sectoral action (MSA) in NCD policies and programs in five African countries, 
b)  to share progress in NCD prevention and control initiatives (including policies and actions) in se-
lect African countries, and 
c) to identify Africa NCD research priorities and formation of a collaborative research Network.
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PARTICIPANTS
The conference drew more than one hundred fifty participants and researchers from various sectors in-
cluding the academia, civil society, and state actors – mainly ministers of health, international NGOs, the 
WHO, health care providers and practitioners of both allopathic and alternative medicine, the private 
sector and patient support groups. In addition, there were several researchers from several institutes in 
Kenya, South Africa, Nigeria, Cameroon, Uganda, Tanzania, Rwanda, Burundi, Malawi, Belgium, USA 
and Canada who attended the conference.
THE CONFERENCE STRUCTURE AND PROCEEDINGS
Each conference session had a chair and at least two rapporteurs. The sub-theme for the first day was 
Multi-sectoral action in NCD prevention and control. There were key note speeches from the confer-
ence hosts namely, representatives from; the EANCDA, the African Population and Health Research Center, 
and the International Development Research Centre (IDRC) as funders of the conference. Other remarks 
were delivered by a representative from the World Health Organization-AFRO office and the Kenyan Min-
istry of Health. Remarks centered on the herculean threat posed by rising NCDs to health of populations 
and economic development and social well-being, and also highlighted the broad outlook of the NCD 
response situation in Africa as pertains policy, programs and research.
The first day had a total of eight presentations. Initial presentations reported on the Analysis for Non-com-
municable Disease Prevention Policies in Africa (ANPPA) project-that sought to analyze the status of NCD 
prevention policies in five African countries (including South Africa, Malawi, Nigeria, Cameroon and 
Kenya) and the role of multi-sectoral action (MSA) in the NCD policy formulation and implementation 
processes. What then followed were highlights on the economics of NCDs control and in particular anal-
ysis on restrictions on tobacco and alcoholic beverages in Kenya. The sub-theme for the second day was 
NCD prevention and control initiatives. Introductory remarks were delivered followed by a set of eight-
een presentations mainly focusing on the global NCD advocacy and priorities (perspectives from NCD al-
liance), the WHO-AFRO NCD Monitoring framework, Health metrics in NCD Research, as well as on 
Poverty and NCDs. Within the same day, presenters shared some of the ongoing NCD research projects 
across Africa and abroad. Later on, NCD country representatives presented on the status of NCD research, 
policy and actions in East African countries. On the final day, the conference sub-theme was NCD re-
search priorities and formulation of collaborative networks. The first session commenced with a pres-
entation on research regulation in East Africa and funding opportunities available for NCDs research. 
During the second session, three working groups were formed to address the following questions:
(i) what should be the priority NCD research themes and agenda in Africa?,
(ii) What are the possible NCD research communication and networking mechanisms in Africa?,
(iii) what is the framework for NCD research collaboration in Africa?
This paper highlights the proceedings of the three-day NCD conference while providing thumbnail sum-
maries of presentations and discussions covering the various aspects of NCDs in developing countries.
Multi-sectoral Action in NCD Prevention in Africa (ANPPA PROJECT)
There are increasing calls to utilize multi-factorial and multi-sectoral approaches (MSA) in NCD preven-
tion and control efforts [21]. MSA refers to actions undertaken by sectors outside the health sector, with 
or without collaboration with the health sector, on health or health- related outcomes or the determinants 
of health or health equity [22]. The high and rising NCD burden and that of its risk factors stems from 
many social and economic determinants like globalization, trade and marketing, demographic and eco-
nomic transitions, leading to behavioral and metabolic risk factors [26]. Most of these determinants of 
health are exterior to the purview of the health sector. This implies that effective NCD prevention and 
control efforts need to include participation from non-health sector actors (such as trade and commerce, 
agriculture, education, urban planning, and transportation) [27]. The WHO, through its global strategy 
for NCD prevention and control, has advocated for a ‘whole-of-government’ approach (in which public 
service agencies work across portfolio boundaries to achieve shared health goals) and also identifies MSA 
as critical for NCD prevention at population level. Also, WHO 2008–2013 Action Plan for Prevention 
and Control of NCDs identified several “best buy” interventions for NCD prevention including measures 
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to reduce the common NCD risk factors. These best buys overlap across several sectors, and their im-
plementation require participation from multiple actors [18,28]. Successful application of MSA ap-
proaches has been reported in several high-income settings, for instance – in tobacco control initiatives. 
However, such evidence on the mechanisms of application and success of MSA for the control of other 
NCD risk factors (ie, harmful use of alcohol, physical inactivity and unhealthy diets) is very limited in 
SSA. The “Analysis for Non-communicable Disease Prevention Policies in Africa” (ANPPA) project im-
plemented by APHRC aimed to generate evidence on the extent to which countries have applied MSA 
in developing policies to prevent NCDs in six SSA countries particularly –Kenya, Malawi, Nigeria, Cam-
eroon, Togo and South Africa. Findings of this study provide a deeper understanding of the processes 
through which MSA is actualized, including the challenges, constraints and enabling factors [23].
The ANNPA project findings revealed a poor understanding of MSA and how it should be operation-
alized. Despite the availability of a WHO toolkit on MSA implementation for NCD prevention, few 
countries have domesticated this document and applied it. In majority of SSA countries studied – ques-
tions still linger as to the precise definition and taxonomy of the term “non-state actors” and also the 
criteria to be applied to identify and ensure broad representation of all sectors in MSA teams. In some 
countries, there are existing inter-agency committees which form basis for MSA, while for some, MSA 
participation is based on invitation. Broad involvement of patients, normal citizens, women or con-
sumers in the MSA processes is poor, yet these groups are critical in NCD advocacy beyond govern-
ment sectors. Case studies from most of ANPPA countries showed that legislation does not necessarily 
translate into implementation, for example, enforcement of tobacco legislation depends on the securi-
ty sector, but most often this sector is not included in NCD policy making. Therefore, there is need to 
shift focus and invest more on effective mechanism of policy enforcement, MSA implementation ac-
countability, and monitoring and evaluation framework. Investment in awareness programmes within 
sectors is also a critical enabler of MSA.
Conference panelists noted that NCDs need to be reframed not only as a public health agenda but more 
importantly as an economic, social and development issue. This would most likely achieve greater buy-
in from policy makers and other non-health sector actors when communicating NCD prevention needs. 
In addition, sufficient explanation should be provided to the non-health sectors on the potential bene-
fits of adopting MSA approaches to NCD prevention. Conference panelists pointed out that certain MSA 
models have been successfully applied to support supply of essential drugs and medicines, there is broad 
consensus that these could be leveraged for NCD prevention. In terms of MSA implementation – most 
national ministries of health are not capable of convening inter-agency group meetings, however, the 
Office of the Presidency has the oversight mandate and capacity and therefore NCD units need to in-
volve the presidency in international treaties targeting NCDs so as to support instrumentation of related 
treaties and ensure compliance where needed. Also, health sector actors need to participate and be ac-
tively involved in tax reforms and budget making processes as it allows for a chance to provide guidance 
on fiscal measures or influence increased funding for NCD prevention related activities.
Challenges to MSA application identified included sustainable funding which is heavily dependent on 
donor support, most often directed by donor priorities. Also identified were low levels of knowledge 
and awareness on MSA among different government departments in various countries. For instance, 
majority of departments were neither aware of their links to NCDs nor what MSA entails.
Following these findings in select SSA countries, recommendations at country level included, the need 
to establish an expert working group to address critical issues such as actor mapping process, involve-
ment of patients, women and consumers, and to develop a clear context based definition of MSA. Health 
sectors should lead in creating awareness for MSA application, nurture and catalyze actions among 
various stakeholders and define roles for each actor and indicators of monitoring progress in MSA for 
NCD prevention. Furthermore, depending on each country’s context – there may be prioritization of 
specific NCDs, build MSA for these priorities before expanding the effort to other NCDs and risk fac-
tors. To improve coordination of MSA for NCDs, actors have suggested the formation of a chronic dis-
ease commission (a national coordinating body). Having lobby groups in places such as parliaments 
can also support NCD advocacy efforts. At the regional and international levels, having an internation-
al ombudsman to pressure national governments to prioritize NCD prevention and control is preferred. 
In conclusion, MSA for NCD prevention needs to be dynamic and adjust to the local realities as there 
is no one size fits all.
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NCD prevention and control initiatives in SSA
Estimating the burden of NCDs in SSA-findings from the 2015 Global Burden of Disease study
The burden of NCD-associated morbidity and mortality is heavy and rising rapidly especially in the SSA 
[1]. From 1990 to 2015, NCD deaths increased from 25% (1.7 million) to 34% (2.7 million) of total 
deaths in SSA. Majority of these deaths were caused by CVD (12%), cancer (7%), and diabetes (5%) of 
total deaths [29]. With regards to health loss, CVDs are ranked 6th leading causes of Disability-Adjusted 
Life Years (DALYs) whereas diabetes, mental and substance use disorders and cancers are ranked 9th, 
10th, and 11th respectively. In addition, from 1990 to 2015, the health loss associated with CVDs and 
diabetes increased by 40% and 46% respectively [30]. Significant differences in prevalence are also wit-
nessed across countries in the SSA. For instance, 7.2 million Nigerians have CVDs compared to 3.7 mil-
lion Ethiopians and 2.8 million South Africans. About 4 million South Africans suffer from diabetes, this 
compared to 3.2 million in Nigeria and 2.2 million in DRC [31]. High blood pressure, poor diets, and air 
pollution top the list of risk factors for health loss from NCDs in SSA [29]. Nearly 6% of DALYs and 15% 
of deaths in SSA are due to high blood pressure and unhealthy diets. Other metabolic risk factors such 
as high BMI and high blood glucose are also leading risks of NCDs. Variations in NCD risk factors based 
on gender are also evident [32,33]. Discussants decried the impact of NCDs in SSA, and the effects it has 
on low and middle social economic households where the cost of illness not only represents much of the 
direct costs of medical care, but also has an impact on family disposable incomes. Also noted were the 
deficiencies in addressing NCDs from basic science research and medical training to health service deliv-
ery, population-wide interventions and access to essential medicines and technology in Africa. There was 
consensus that more efforts are needed to enhance a robust primary health care system that focuses on 
the social determinants of health, as well as promoting early screening and treatment.
World Health Organization Regional Office for Africa (WHO-AFRO) – NCD Monitoring 
framework
In consolidating NCDs prevention and control as well as improving the coordination of these efforts, sev-
eral global and regional initiatives have been established. In September, 2011, the United Nations (UN) 
high level meeting (HLM) of Heads of State and Government met to affirm political commitment against 
NCDs and prioritized NCDs prevention and control [34]. In 2012, the World Health Assembly (WHA) 
adopted a global target of 25% reduction in NCDs associated premature mortality by 2025 (25 by 25) 
[35]. In 2013, the WHA launched the WHO Global NCD Action Plan 2013-2020, that included 9 vol-
untary global targets and 25 indicators to accelerate national-level efforts to address NCDs [36]. Further-
more, in 2014, a UN General Assembly session was held to assess progress achieved in global NCDs pre-
vention and control efforts and the progress to achieve set targets by member countries was noted as good. 
In same year (2014), the outcome document of the UN HLM of the General Assembly reiterated the same 
roadmap of national commitments, including four time-bound commitments such as setting national 
NCD targets for 2025 or 2030 and monitoring results by 2015; developing a national multi-sectoral ac-
tion plan by 2015; implementing the “best buy” interventions to reduce NCD risk factors by 2016 and 
to strengthen health systems to address NCDs. There are also a set of ten progress monitoring indicators 
designed to track progress in every country [37] (see Box 1).
Box 1. Ten progress Monitoring Indicators (Adapted from the World Health Organization, 2015) [37]
  1. Set National NCD targets and indicators
  2. Accurate mortality data by each country
  3. Conduct Risk factor surveys utilizing the standardized STEPwise survey methodology.
  4. Develop a National integrated NCD strategy and action plan
  5. Set measures to regulate tobacco demand by using taxation, smoke-free policies, health warnings and bans
  6. Reduce harmful use of alcohol using available regulations, pricing policies, advertising and promotion bans
  7.  Reduce exposure to unhealthy diet using salt/sodium regulation policies, saturated fatty acids and trans-fats 
policies, and marketing to children restrictions, restrict marketing of breast-milk substitutes.
  8. Public awareness on diet/physical activity
  9. Guidelines for the management of major NCDs
10. Drug therapy/counseling for high-risk persons
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The Sustainable Development Goals (SGDs) agenda were unveiled in 2015. Goal 3 aims at health and 
welfare. NCDs are particularly captured in several strategic objectives such as reduction of NCD related 
mortality through health promotion, NCD prevention and treatment of common NCD risk factors, re-
duction in deaths and injuries from road traffic accidents. The SDGs also call for expansion of universal 
health coverage (UHC), strengthening and implementation of the World Health Organization Framework 
Convention on Tobacco Control (WHO FCTC), support of research and improvement of access to af-
fordable essential medicines and vaccines, substantial increase in health financing and human resource 
capacity, and elimination of all forms of violence against women and girls [38]. Conference participants 
acknowledged the existing frameworks that support the coordination and monitoring of efforts to address 
NCDs. While NCD prevention and control progress indicators in most African countries remain subop-
timal, the WHO AFRO NCD monitoring framework serves to raise awareness and reinforce political com-
mitment.
Challenges experienced in prevention and control of NCD
Despite the considerable progress made in developing and adopting a global NCD strategy, several coun-
tries in SSA have been slow to translate the global strategy into comprehensive national policies and plans, 
thereby affecting their effective implementation. Other factors that impede efforts to address the NCD 
burden include; a) incomplete NCD burden data which is grossly underestimated because NCDs such as 
sickle cell diseases, mental illness, injury and suicide are poorly documented and not included in the re-
ported data, b) low (even though increasing) knowledge and awareness on NCD burden, drivers and im-
pact hinders attempts to adopt healthy behaviors and also the uptake of early screening and treatment of 
NCDs such as cervical cancers and hypertension, as well as adherence to treatments to achieve blood 
pressure control, c) the national policies and plans for the prevention and control of NCDs are often un-
derfunded, d) the non-availability of relatively inexpensive medications used for managing chronic NCDs 
in public sector facilities is a key challenge limiting the ability to address effectively the management of 
NCDs, poverty, which is widely common among residents of LMICs, including SSA plays a fundamental 
role in the onset, progress and mortality of NCD patients. Majority of individuals with chronic diseases 
in these low resource settings resort to out-of-pocket payment, which then drives the already poor to 
more abject poverty. While the social and economic implications of NCDs remain scarcely characterized 
in most SSA countries, this information is important as it may attract prioritization of NCDs by all rele-
vant sectors, and raise the political commitment needed to effect national and regional action against 
NCDs. Also, there is constant interference from the commercial and economic interests of tobacco, alco-
hol and food industries making it difficult to control their activities that continue to drive key NCD risk 
factors. Conference discussions focused on identifying opportunities to address these challenges, and 
suggestions included that high-level policy makers should prioritize NCDs and provide adequate fund-
ing to national policies and plans aimed at promoting healthy lifestyles and that of prevention and control 
of NCDs. Also noted, was the need for increased research and reporting of socio-economic consequenc-
es of NCDs among the poor and vulnerable, and the application of innovative and sustainable solutions 
that can be incorporated as part of broader development frameworks.
Poverty and NCDs – Case study from Rwanda. Conference presentations highlighted trends in urban-
ization across several towns in Africa, and mostly characterized by increased rural-urban migration [39], 
and significant changes in the patterns of health and disease [40]. Other factors such as emergence of 
slums, overpopulation, and urban poverty have aggravated health statuses of individuals in SSA [41,42]. 
Perhaps the most at risk groups to NCDs in the next decade will be the urban poor, who thrive within 
complex nutrition, food systems as well as physical activity environment [43]. Most urban settings face 
issues such as insecurity concerns, lack of organized markets, inadequate resources for physical activity, 
and poor housing (risking indoor pollution)- all promoting risks for NCDs. Significant proportions of the 
population in these urban poor settings have limited healthy lifestyle options [44]. As observed in Rwan-
da in 2015, NCDs were responsible for 35% of all deaths, 52% of all outpatients’ consultations and 22% 
of all hospitalization in district hospitals. The greatest contributors of NCDs associated DALYS in Rwan-
da included congenital anomalies, unipolar depression, asthma, epilepsy, chronic obstructive pulmonary 
disease (COPD), diabetes, cervical cancer, and rheumatic heart disease [45]. While the NCD burden in 
most HICs is driven by traditional risk factors (ie, obesity, tobacco use, and other factors collectively termed 
“poor lifestyle” choices), Rwanda’s NCD epidemiology is significantly linked to malnutrition, infections, 
and toxic environments- factors all exacerbated by poverty [46]. Similarly, individuals exposed to NCD 
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risk factors increase across the decreasing economic strata [47]. In addition, individuals of lower socio-
economic status (SES) tend to have limited access to health services, including screening, early diagnosis 
and treatment, as well as poor adherence to health promotion messages and therapy. NCDs may drive 
individuals and households to poverty through loss of earnings and reduced productivity [48], as well as 
catastrophic health care expenditures [48,49]. Increased recognition of the role of poverty in NCDs has 
accelerated efforts to re-framing NCDs and injuries for the poorest billions in LLMICs [5]. Nevertheless, 
in Rwanda, interventions to address poverty and NCDs are vanishingly scarce. The Rwanda Economic 
Development Poverty Reduction Strategy (EDPRS II) (2013-18) have an overarching goal of poverty al-
leviation, while the national NCD policy targets creation of health promoting environments, support to 
community actions to reduce exposure to modifiable NCD risk factors and injuries, as well as strengthen 
and mainstream NCDs programs within the national health systems. However, there is no cooperation 
links between these generalized efforts to address poverty on one hand and NCDs on the other. Despite 
the existing link between poverty and NCD, global funding for health and NCDs is tilted in favor of the 
rich countries with 60% of total funding going to upper-middle income countries, 35% to lower-middle 
income countries and only 5% to low-income countries [50,51]. Therefore, the countries with the largest 
burden of disease receive the least amount of financial support to address NCDs.
Examples of ongoing NCD prevention and Control Projects
Researchers shared examples of ongoing initiatives undertaken to prevent and control NCDs in the vari-
ous SSA countries, including those focusing on: (i) legislation (eg, to control tobacco and alcoholic bev-
erages), (ii) models of NCD care (eg, integration of NCD primary care to strengthen health systems), (iii) 
advocacy to improve access to essential medicines and technologies for NCDs, and (iv) policies and direct 
actions to modify NCD risk factors. Key highlights of these ongoing NCD projects are as shown below.
Research to guide practice: Enhancing HIV/AIDS platforms to address NCDs in low-resource set-
tings (PEPFAR-NCD project). The remarkable progress made in confronting the global HIV epidemic 
offers profound opportunities to address the increasing threat of NCDs in people living with HIV (PLHIV) 
and across general populations. However, questions remain about how to enhance the HIV platforms to 
deliver integrated HIV and NCD care to PLHIV in SSA. The PEPFAR-NCD project involved researchers, 
policy implementers and government representatives to explore approaches to improve evidence neces-
sary to enhance the gains in HIV/AIDS prevention and control while addressing rising burden of NCDs. 
The National Institutes of Health (NIH), with leadership from the Center for Global Health Studies (CGHS) 
at Fogarty, implemented the project in collaboration with the President's Emergency Plan for AIDS Relief 
(PEPFAR) and over 70 active participants. While the primary focus of this project was to expand care for 
chronic NCDs for people living with HIV (PLWH), the ultimate goal is to generate evidence supporting 
investments to have health care systems that are comprehensive for all prevalent health needs in low-re-
source settings. So far, the project has delivered outputs including; i) landscape analysis through exam-
ining peer-reviewed and grey literature on integration of priority NCDs into existing HIV health systems 
and care protocols in LMICs, in addition to identifying a possible HIV/NCD research agenda for low re-
source countries, ii) conducted a workshop in Washington DC, USA of researchers, national program 
implementers and policy makers from eight countries in SSA, and research organizations in the US, to 
explore existing models on integrated HIV and NCD care, iii) supported a call for HIV and NCD data 
modeling proposals to develop approaches to estimate the burden of NCDs (such as cervical cancer, di-
abetes, depression and cardiovascular disease) in PLHIV in SSA. More recently, the project has supported 
development of 11 supplement articles to be published in the AIDS journal. These set of eleven supple-
ment papers provide greater details on various integrated HIV/NCD components (such as policy, NCD 
medicines supply chain, economics of integration and global partnerships).
Healthy Heart Africa. Healthy Heart Africa (HHA) program has committed to tackling hypertension and 
the raising burden of cardiovascular diseases (CVDs) in Africa. Funded by AstraZeneca, the program aims 
to reach up to 10 million hypertensive patients across Africa by 2025. It spreads across 24 counties in 
Kenya, and there are plans to expand to other countries in Africa. While the HHA program anticipates 
the significant barriers to access of CVD prevention and management care, it uses a model with three key 
pillars including: i) Increasing education and awareness on hypertension, its risk factors and available in-
terventions for prevention and treatment, ii) conducting training of health providers (including nurses) 
while driving care to lower levels of health care system, and support development of guidelines appro-
priate for community-based implementation, iii) facilitating access to essential medicines and technolo-
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gies (EMTs) by developing supply chain and distribution models that improve access to low cost, high 
quality branded anti-hypertensives. To enable the building of local capacity – the program has joined 
forces with six local partners across the private, public and faith-based sectors in Kenya at every level of 
care, to create a demonstration model that works for the country. HHA also uses collaborations with Ken-
ya’s Mission for Essential Drugs and Supplies (MEDS), to establish secure supply chains for anti-hyper-
tensive medicines, and with Savannah, a Kenyan data management company, to allow for continuous 
monitoring of program outputs and patient level data capture.
Integration of NCD primary care into HIV – pilot project in Kenya. NCD primary care services in 
most low resource settings including Kenya are still nascent, compared to other more established health 
service delivery platforms (such as HIV/AIDS, Maternal and Child Health (MCH), and Family Planning 
(FP)). There has been increasing interest to leverage on the existing resources within these well-estab-
lished disease platforms, to achieve enhanced NCD prevention for populations in Kenya. However evi-
dence is scarce on how exactly to implement these attempts. The NCD care integration pilot project, sup-
ported by the Grand Challenges Canada was implemented by the Aga Khan University, Kenya. The 
project implemented systematic NCD screening (ie, risk factors for CVDs, chronic obstructive pulmonary 
disease, cervical cancers) among routine patients attending the HIV clinic and other primary health care 
(PHC) units (such as mother child health (MCH) and family planning (FP) clinics) at a rural sub county 
hospital in Kenya. Findings from the NCD integration into PHC settings revealed increased knowledge 
and awareness on NCDs among existing PHC staff and patients, improved skills in NCD care, improved 
NCD and risk factor detection, improved ability to offer NCD counselling and referral services even with-
in lower cadre facilities. Similarly, a study on NCD/HIV integration by the Medicines Sans frontiers (MSF) 
in Kibera slums (Nairobi) and in Embu, revealed that integration improved detection of NCD cases with-
in routine HIV clinics, and also increased capacity by health staff to attend to more new cases. With the 
increase in research and data on feasibilities of HIV and NCD integration including some positive results 
from the pilot studies in Kenya, Uganda, and South Africa – there are calls to reorient health systems to 
address the prevalent heath needs of primary care attendees. Such results can be used to inform resource 
allocation (personnel and funding), and planning in the health sector for NCDs (ie, resources to follow 
needs). Nevertheless, not all attempts to integrate NCDs produce positive results, indeed integration into 
other vertical platforms may carry along risks such as dilution of outputs from high profile vertical dis-
ease programs, such as HIV programs. Further research is needed to build more evidence on what can be 
integrated, and how integration can better be done, as well as outcomes of integration on other programs, 
on NCDs services, on staff effectiveness and to answer cost-effectiveness questions.
Strategies for access to Essential Medicines and Technologies (EMTs) for NCDs – Advocacy in 
NCD. The situation in LMICs is that most essential drugs for NCDs (eg, diabetes) are rarely available in 
80 percent of public or private facilities, and are least available in the public sectors, rural areas, and at 
the lowest levels of care. What is also known, for instance in Kenya, is that prices are higher in private 
health facilities than public facilities. Moreover, different counties have varied infrastructure levels for ac-
cess to essential medicines and technologies (EMTs) for NCDs. These and several other factors inevitably 
restrict overall access to essential medicines and technologies (EMTs) to manage NCDs. Moreover, in most 
countries, drug stocking is not need-based, and allocations is not informed by client affordability. Sever-
al models of interventions have been attempted by organizations such as PATH International, to improve 
access to EMTs including, raising awareness of availability and affordability of EMTs for diabetes, and in-
spire a wide range of stakeholders at the global and national levels to act and address this challenge. While 
recognizing that the current approaches and systems for procurement and distribution of diabetes EMTs 
are neither efficient in most of SSA, nor are they meeting existing needs, there is need for proper financ-
ing which includes dedicated budget for NCDs; strengthening of Health system to include NCD in all 
primary care settings and formulation of standard guidelines; supply chain management improvements; 
improvement in policies and governance.
Tobacco and alcoholic beverages control in Kenya – Economics of NCD control. Implementing in-
creased taxation and restrictive policies on unhealthy products, such as tobacco, alcoholic beverages and 
sugar sweetened drinks, can produce major health gains for the poorest in society. Though regulation on 
sugary drinks has been limitedly implemented, this year, five countries, including Ireland, the United 
Kingdom and South Africa, will join 26 nations who have raised prices of sugary drinks. Kenya is among 
the LMICs countries which has implemented increased taxation on tobacco (from around 2005/2006) 
and regulation of alcoholic beverages by an act of parliament in 2010. An analysis of this tax and price 
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regulation in Kenya revealed that it led to higher levels of alcohol and tobacco abstinence compared to 
other countries in the region. Taxation on these products implies availability of a huge potential market 
for these products in Kenya. Most importantly, taxation alone as a health promotion intervention, has 
limited reach in minimizing exposure to alcoholic substances since majority (more than 58%) of the al-
coholics consume home brewed alcohol in Kenya. Nevertheless, taxation remains an important regula-
tory tool that needs to be extended on sugar sweetened drinks. There are suggestions to standardize tax 
on alcoholic drinks and base it on the alcoholic content in a given beverage rather than volume of the 
whole beverage as is the current practice. This would raise taxes on spirits since they have higher alco-
holic content. However, caution should be exercised in this regard since increased taxation of alcoholic 
drinks could trigger a shift by most consumers to home brewed alcohol (which is unregulated), thus ren-
dering the tax policy ineffective. Ironically, one approach to decrease consumption of home brewed alco-
hol is to reduce the cost of beer. Stability of tax regime is needed to in order to allow assessment of impact 
of taxation on alcohol and tobacco in a given setting. Also, there is need to explore additional mechanisms 
to bend downwards the demand curve for tobacco and alcohol use.
NCD research priorities and collaborative networks for Africa
Research regulation – using the East African Context
Regulations in medical research is guided by principles including; respect for persons (autonomy), be-
neficence and justice which are operationalized in ethical guidelines. Ethical guidelines set standards for 
the conduct of research and contributes to the quality and consistency in ethical review. While there are 
modest growth seen in ethical reviews for research in the East African region, there are increasing demands 
by researchers to improve on the process and time taken to approve research proposals. There is need for 
cooperation between different committees in the review of multi-center studies (especially those involv-
ing more than one country), requiring more than one review for these multiple reviews to occur effec-
tively. Cooperation of different ethical review bodies across different countries shortens time for review 
and administrative quality control is embedded in products of such cooperation. Available modes of co-
operation include having joint committees (integration), regional committees (joint review) and collabo-
ration. Also, the main opportunities for integration of the review process exist in international frameworks 
such as the “WHO, UNESCO Universal Declaration on Bioethics and Human Rights” and using the re-
gional cooperation frameworks such as the East African Cooperation Protocol and the African Union.
Research funding opportunities for NCDs in Africa
Funders present at the conference included, the International Development Research Centre (IDRC), 
GlaxoSmithKline (GSK), Astra Zeneca, and Novo Nordisk. They all shared their respective funding op-
portunities relevant to NCDs, while highlighting their priority program areas and ongoing projects being 
supported. On its part, Astra Zeneca dedicates approximately US$4.9 billion in Research & Development 
across five countries, with focus on CVDs & metabolic diseases, oncology, respiratory, inflammation & 
autoimmunity diseases, and supports local academic medical research in NCDs. Some of the projects cur-
rently being supported include, “Healthy Heart Africa (HHA)” program and the “Young Health Programme” 
which focuses on NCD health promotion among adolescents. In addition, “phakamisa” is AstraZeneca's 
access program to increase capacity of health care professionals to diagnose and treat breast and prostate 
Cancer. Novo Nordisk focuses in diabetes care and other chronic conditions such as growth disorders 
and obesity. Together with its partners, Novo Nordisk has aimed to develop scalable and sustainable solu-
tions that enhance access to diabetes care by building health care professionals’ capacities and providing 
better access to chronic disease care in 22 African countries. The IDRC’s 2015 - 2020 focus is on food, 
environment and health programmes. With regards to NCDs prevention, IDRC supports food systems 
research for prevention of food-related chronic diseases and tobacco control research. IDRC has also fund-
ed research aimed at understanding the economics of NCDs prevention and control interventions, such 
as research in South Africa to explore the economic arguments for and against legislative and fiscal poli-
cies to improve nutrition, economic modelling of NCD burden and innovative financing mechanisms for 
health. GlaxoSmithKline (GSK) conducts research, develops and manufactures innovative medicines, 
vaccines and consumer health care products. It supports the Africa NCD open Laboratory programme, 
which is a virtual research and development laboratory that shares research expertise and resources with 
funders, researchers and stakeholders to conduct NCD clinical & translational research in Africa.
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NCD research themes and priorities in Africa
The causes of NCDs are multifaceted and include social, economic and even cultural drivers, and simi-
larly, opportunities for intervention and research exist at various levels such as individual, community 
and national/international levels. Interventions can be at various stages such as at health promotion and 
prevention, treatment, care and rehabilitation. Conference participants developed a broad range of re-
search priorities to form the basis for the regions response to tackling the rising burden of NCD, as de-
tailed in Table 1.
Framework for collaboration and research coordination in Africa
Participants of the conference discussed relevant multidisciplinary networks and coordination frameworks 
for NCD research and modalities of collaboration between NCD researchers that allows for maximum 
leveraging of existing resources within African countries and support the NCD control efforts. These in-
itiatives would be channeled through existing regional networks or country alliances (Figure 1).
Table 1. Non-communicable diseases (NCD) research themes and priority projects
NCD themes What the theme eNtails Priority ProjeCts
a) NCD Prevention and 
treatment
Efforts to; understand social causes of NCDs, improve ac-
cess to medication, adherence, and health services, behavior 
change for NCD prevention, prioritize NCD “must buys”. 
Improve access to rehabilitation/referral services
1. Situational Analysis – data available, policy – evaluation 
2.  Implementation, monitoring and evaluation of “must buys”
b) NCD data and 
surveillance
Efforts to build health information systems to collect qual-
ity and routinely update data on NCD associated Morbidity 
and mortality.
1.  Assessing the availability, quality, accuracy and completeness 
of data already collected
2.  Improve mechanisms of conducting sentinel or routine risk 
factor surveillance
c) Health systems 
research
Efforts to understand and improve how health services are 
organized to achieve health goals, and how different actors 
interact in the policy and implementation processes to con-
tribute to policy outcomes.
1. Assess models of health system integration
2. Assess effectiveness of chronic care models
3.  Innovative ways to improve funding, payment and access to 
medicines, vaccines and technologies to remote populations
d) Economics in NCDs Efforts to quantify the cost of NCD burden, cost of NCD in-
terventions; cost of inaction; cost of various service delivery 
models, understanding the politics of resource allocation in 
health; economics of sin taxes, innovative financing, health 
insurance and minimizing out of pocket payments.
1.  What is the cost-effectiveness of the NCD “best-buy” inter-
ventions
2. Explore the politics of health resource allocation
3.  Effects of NCD interventions on behavior change for NCD 
prevention
e) NCD policy research Understanding the impact of NCD related policy on preven-
tion of diseases, effects on other sectors, implementation 
researchers
1. Assessing the impact of NCD policy
2. Mechanisms of MSA applications in policy formulation
Figure 1. Framework for non-communicable diseases (NCD) research coordination: the case 
of East African region.
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Modes of research collaboration between these institutions and groups (seen in Figure 1) included; a) 
submission of joint proposals, b) engaging in capacity building through exchange programmes, c) con-
ducting multi-country comparative projects, and d) sharing research outputs, expertise for implementa-
tion and conferences, and workshops.
Research communication and network. Conference participants proposed structure and mechanisms of 
communication and sharing of research opportunities and outputs. An organizational framework and a 
platform for communication and resource sharing was generated as illustrated below.
Organizational Structure: a three-tier structure was modelled along the African NCD research network 
resolutions developed in Mauritius in 2016. The tiers included a;
a) Continental committee of five leading NCDs researchers
b)  Regional committee made up of representatives from the East, West, Central, North, and south 
regions of Africa
c) National committees based at country levels
Modes of Communication: the modes used for communication and sharing of NCD research progress 
and outputs within the African region included:
a) An African NCD Network Website
b) Quarterly newsletters
c) Africa non-communicable disease journal
d)  Social media channels such as Facebook, Twitter, LinkedIn, Youtube channel, mySpace, Flickr 
views
CONCLUSIONS
Overall, the first Africa NCD conference was successful in managing to draw consensus among the dele-
gates on how to address rising burden of NCDs through research interventions, set priorities and collabo-
rations. Conference participants agreed on the need to reframe NCDs not only as a public health agenda 
but more importantly as an economic, social and development issue. This would improve buy-in from 
other non-health actors and adoption of MSA approaches to NCD interventions. In addition, there is need 
to define and expand the composition of MSA teams to include a wider representation. There are many 
existing multidisciplinary networks that simply require a coordination framework for NCD research and 
modalities of collaboration between NCD researchers in SSA. This coordination and leveraging of strengths 
would allow for maximizing of resources within and across countries and create synergy in NCD preven-
tion and control efforts.
Furthermore, resources and capacities in the south and north can be shared for improved research outputs. 
Key modes of research collaboration between these institutions would be: a) submission of joint proposals, 
b) engaging in capacity building through exchange programmes, c) conducting multi-country comparison 
projects, and d) sharing research outputs, expertise for implementation and conferences, and workshops.
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